These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4166819)

  • 1. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
    Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
    Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
    [No Abstract]   [Full Text] [Related]  

  • 3. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Normal sequential treatment. experiences with an 11:10 variant of the sequential method for contraception and for medical indications].
    Schmidt H; Langner A; Kaiser R
    Munch Med Wochenschr; 1970 Oct; 112(42):1903-13. PubMed ID: 4097638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications for the treatment with sequence preparations].
    Breckwoldt M; Bettendorf G
    Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with Ovosiston in a new dosage form].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 11. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
    Kalchauer B
    Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
    Matthews AE; Clarke JE
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Menstruation disorders due to Ovosiston medication].
    Kühndel K; Ebeling K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Personal experience in the management of the post-menopausal patient using sequential 11 plus 10 therapy (mestranol 30 mcg. and chlormadinone 1 mlg. plus mestranol 80 mcg)].
    González Gutiérrez JT
    Ginecol Obstet Mex; 1969 May; 24(151):531-7. PubMed ID: 4186794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sequential therapy in menstruation disorders].
    Gaudefroy M; Lefebvre F
    J Sci Med Lille; 1968 Oct; 86(10):581-606. PubMed ID: 4097276
    [No Abstract]   [Full Text] [Related]  

  • 19. [Steroid metabolism in primates. XVIII. Return to higher levels of 17-ketosteroid excretion in urine after ending a long-term treatment with mestranol/chlormadinone acetate in the baboon].
    Gontscharow NP; Woronzow WI; Schön R; Hobe G; Schubert K
    Endokrinologie; 1976 Jul; 67(3):362-4. PubMed ID: 61857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hopes and failures concerning small-dosage chlormadinone].
    Souleau J
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(2):185-6. PubMed ID: 4097505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.